How to Plan for the Obesity Drug Revolution

What You Need To Know

• Life insurers are starting to think about what Wegovy, Saxenda and successors could do for your clients.
• Fewer obesity-related health complications could mean many clients will have different long-term financial planning needs.
• The drugs still come with high costs, unpleasant side effects, and the possibility that they will work better for some people than others in the long term.